1. Academic Validation
  2. Two new phenylpiperazines with atypical antipsychotic potential

Two new phenylpiperazines with atypical antipsychotic potential

  • Bioorg Med Chem Lett. 2007 Nov 1;17(21):5749-53. doi: 10.1016/j.bmcl.2007.08.066.
Mirko Tomić 1 Djurdjica Ignjatović Gordana Tovilović Deana Andrić Goran Roglić Sladjana Kostić-Rajacić
Affiliations

Affiliation

  • 1 Department of Biochemistry, Institute for Biological Research, Bul. Despota Stefana 142, 11060 Belgrade, Serbia. mitomic@ibiss.bg.ac.yu
Abstract

Two new series of substituted arylpiperazines with heterocyclic 3-propoxy-benzimidazole or 3-propoxy-benzimidazole-2-thione groups were synthesized and their in vitro binding affinities for the D(2), 5-HT(1A), 5-HT(2A), and alpha(1)-adrenergic receptors determined. Among them, only two compounds with phenyl aryl-constituent (8a and 9a) showed 5-HT(2A)/D(2) pK(i) binding ratios proposed for atypical neuroleptics. As to their behavioral screening on rodents, both compounds exhibited a non-cataleptic action in rats and antagonized D-amphetamine-induced hyperlocomotion in mice, suggesting their possible atypical antipsychotic potency.

Figures